Related Experiment Video
Updated: Aug 12, 2026
12:36
Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology
Published on: March 14, 2020
[Peptic ulcer in liver cirrhosis]
A Giacobbe1, D Facciorusso, P Conoscitore
1Divisione di Gastroenterologia ed Endoscopia Digestiva, Ospedale Generale Regionale, Casa Sollievo della Sofferenza di San Giovanni Rotondo (Foggia).
Minerva Dietologica E Gastroenterologica
|October 1, 1990
Summary
Cirrhotic patients have a similar risk of developing peptic ulcers as the general population. Alcohol and smoking are key risk factors for peptic disease in these individuals.
Area of Science:
- Gastroenterology
- Hepatology
- Internal Medicine
Background:
- Peptic ulcer disease (PUD) is a common gastrointestinal condition.
- Cirrhosis, a severe form of liver disease, can alter physiological processes.
- The prevalence of PUD and associated risk factors in cirrhotic patients requires clarification.
Purpose of the Study:
- To determine the frequency of peptic ulcer disease in patients with cirrhosis.
- To investigate the role of potential ulcerogenic risk factors in this population.
Main Methods:
- Retrospective study design.
- Evaluation of cirrhotic patients' medical records.
- Analysis of risk factors including alcohol consumption and smoking.
Main Results:
- Peptic disease was observed in 18.2% of examined cirrhotic patients.
- This prevalence is comparable to that in the general population.
- Alcohol and smoking were identified as significant ulcerogenic risk factors.
- Etiology of cirrhosis and portal hypertension were not significant factors.
Conclusions:
- Peptic disease is not more frequent in cirrhotic patients compared to non-cirrhotic individuals.
- Alcohol and smoking are crucial risk factors for peptic ulcers in cirrhosis.
- Further research may focus on preventative strategies targeting these modifiable risk factors.
Related Concept Videos
01:30Peptic Ulcer Disease I: Introduction
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
01:26Peptic Ulcer Disease IV: Management
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
01:27Peptic Ulcer
Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...